KPTI · Karyopharm Therapeutics Inc.
$6.96
-0.13 (-1.83%)
At close · Jul 29
Going-concern doubt
— flagged May 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on our current business plan and current capital resources, combined with the uncertainty regarding the availability of additional funding or other strategic alternatives and considering our debt service obligations and financial covenant to maintain minimum liquidity, we have concluded that there is substantial doubt regarding our ability to continue as a going concern within one year after the date the accompanying condensed consolidated financial statements are issued.”View the 10-Q filed May 14, 2026
Market Cap
$160.68M
Shares
22.66M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-06-30 | 5,682 | $10.09 | $57,331 |
| 2026-06-24 | 86,433 | $9.65 | $834,078 |
| 2026-06-23 | 2,069 | $9.00 | $18,621 |
| 2026-06-22 | 4,081 | $9.02 | $36,811 |
| 2026-06-18 | 1,681 | $9.40 | $15,801 |
| 2026-06-17 | 2,000 | $9.10 | $18,200 |
| 2026-06-15 | 41,748 | $9.50 | $396,606 |
| 2026-06-10 | 2,342 | $8.69 | $20,352 |
| 2026-05-13 | 1,145 | $8.92 | $10,213 |
| 2026-05-11 | 857 | $8.64 | $7,404 |
Showing 1–10 of 10 settlements
Key facts
CIK
1503802
CUSIP
48576U205
13F (30d)
10 filings
10 filers
Visit website
Investor relations